Clinical Trial – Safety and Pharmacokinetic Study of Intravenous Ibuprofen – Fever

The primary objective of this study is to evaluate the pharmacokinetic profile of a single dose of intravenous ibuprofen administered over approximately ten (10) minutes.

 

Study Type: Interventional  (Clinical Trial)
Estimated Enrollment: 24 participants
Allocation: Single Group Assignment
Intervention Model: Multi-center, Open-label
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Multi-Center, Open-Label Pharmacokinetic and Safety Study for Reduction in Fever or Management of Pain in Pediatric Subjects Aged Birth to Six Months
Actual Study Start Date: July 17, 2017
Estimated Primary Completion Date: December 2018
Estimated Study Completion Date: December 2018

 

Contact

Contact: Byron Kaelin 615-255-0068 ext 250 bkaelin@cumberlandpharma.com
Contact: Jerry Fox 615-255-0068 ext 226 jfox@cumberlandpharma.com

 

ClinicalTrials.gov Identifier: NCT02583399

 

For enrollment please visit www.clinicaltrials.gov.

Leave a Reply